| Autor: |
Morris HN; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Winslow AT; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC., Barreiro-Rosado JA; UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC., Torian S; Division of Libraries, New York University, New York, NY., Charlot M; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC. |
| Jazyk: |
angličtina |
| Zdroj: |
JCO precision oncology [JCO Precis Oncol] 2024 May; Vol. 8, pp. e2300708. |
| DOI: |
10.1200/PO.23.00708 |
| Abstrakt: |
The increasing focus on precision medicine to optimize cancer treatments and improve cancer outcomes is an opportunity to consider equitable engagement of people racialized as Black or African American (B/AA) in biospecimen-based cancer research. B/AA people have the highest cancer incidence and mortality rates compared with all other racial and ethnic groups in the United States, yet are under-represented in biospecimen-based research. A narrative scoping review was conducted to understand the current literature on barriers, facilitators, and evidence-based strategies associated with the engagement of B/AA people with cancer in biospecimen research. Three comprehensive searches of MEDLINE, CINAHL, Embase, and Scopus were conducted. Of 770 studies generated by the search, 10 met all inclusion criteria for this review. The most frequently reported barriers to engagement of B/AA people in biospecimen research were lack of biospecimen research awareness, fear of medical harm, and violation of personal health information privacy, resource constraints, and medical mistrust. Key facilitators included previous exposure to research, knowledge about underlying genetic causes of cancer, and altruism. Recommended strategies to increase participation of B/AA people in biospecimen-based research included community engagement, transparent communication, workforce diversity, education and training, and research participant incentives. Inclusion of B/AA people in biospecimen-based research has the potential to advance the promise of precision oncology for all patients and reduce racial disparities in cancer outcomes. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
